[Federal Register Volume 70, Number 228 (Tuesday, November 29, 2005)]
[Notices]
[Page 71560]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-6607]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 14, 2005, and published in the Federal 
Register on April 25, 2005 (70 FR 10683), Penick Corporation, Inc., 158 
Mount Olivet Avenue, Newark, New Jersey, 07114, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic class of controlled substances 
listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Ecgonine (9180)............................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed bulk controlled 
substances in bulk for distribution to its customers.
    Following the Notice of Application publication on April 25, 2005, 
(70 FR 17472-17473), Penick Corporation, 158 Mount Olivet Avenue, 
Newark, New Jersey 07114, relocated its operations to 33 Industrial 
Park Road, Pennsville, New Jersey 08070 on May 18, 2005. DEA conducted 
a full investigation and inspection of the company's security which was 
found to be in compliance with all required regulations.
    One comment was received; however, the comment was not relevant to 
the company's current activities as a manufacturer of Schedule II 
controlled substances.
    DEA has considered the factors in 21 U.S.C. 823(a) and determined 
that the registration of Penick Corporation to manufacture the listed 
basic class of controlled substances is consistent with the public 
interest at this time. DEA has investigated Penick Corporation to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic class of controlled 
substances listed.

    Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
 [FR Doc. E5-6607 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P